跳至主要内容
临床试验/NCT02180945
NCT02180945已完成不适用

ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae. A French, Observational, Prospective, Multicentric, Single Arm and Open Study

Medtronic Neurovascular Clinical Affairs1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
110
试验地点
1
主要终点
Neurological clinical evolution

研究概览

简要总结

The objective of this study is to evaluate the safety and performance post last embolization with Onyx

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient has an intracranial dAVF which could be treated by ONYX embolization, whether or not associated to other embolization products.
  • The patient is at least 18 years of age.

排除标准

  • The patient needs to be treated for the dAVF with another treatment option (for example by surgery) than embolization within a period of less than 6 months (to be counted as from the first treatment)
  • The patient participates to another clinical study during the treatment period for his/her dAVF, evaluating another medical devices, procedure or medication.
  • The patient refuses to give consent to the collection and processing of data required for centralized monitoring.
  • A condition which could jeopardize follow-up of the patient.

结局指标

主要结局

Neurological clinical evolution

时间窗: 1Month post procedure

Improved, Stable, Worsened, death

Healing rate

时间窗: 3-6 months post procedure

Number of patients with No residual early venous return

次要结局

  • Adverse event(3-6 months after procedure)
  • Quality of life EQ-5D(pre-procedure and at 3-6 months)
  • Describe functional independence(1 and 12 months after procedure)
  • Technical performance of the product(12 months after procedure)

研究者

发起方
Medtronic Neurovascular Clinical Affairs
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验